SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Clover Health Investments Corp. is a physician enablement technology company, which engages in the provision of Medicare Advantage plans in the United States. Its strategy is powered by its proprietary software platform, Clover Assistant, which aggregates patient data from across the healthcare ecosystem to support clinical decision-making and improve health outcomes through the early identification and management of chronic diseases. The company offers PPO and HMO Medicare Advantage plans in several states, with a differentiated focus on its flagship wide-network, high-choice PPO plans. The company was founded by Vivek Garipalli and Andrew Toy on July 17, 2014 and is headquartered in Wilmington, DE.

Clover Health Investments Corp - Ordinary Shares - Class A

Clover Health Investments Corp

Clover Health is experiencing a significant surge driven by a successful court ruling that led to a CMS-mandated recalculation of its 2026 Medicare Advantage star rating from 3.5 to 4.5 stars. Community sentiment is highly optimistic, with investors actively discussing this re-rating as a major valuation catalyst that validates the company's AI-driven technology stack and its Counterpart Health business model.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer (SMCI) is experiencing high volatility as shareholders react to a massive seven-billion-dollar capital raise intended to fund a thirty-nine-billion-dollar surge in AI server orders. While the community is sharply divided between those viewing the dilution as a necessary step to capture historic demand and others expressing deep frustration over equity devaluation and management's transparency, many are debating whether the record-breaking backlog justifies the sharp price correction.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is trending as investors debate the impact of ongoing geopolitical volatility in the Middle East and the company's shifting corporate strategy following the cancellation of a planned spin-off. Community sentiment is deeply polarized, with intense discussions focusing on the stock's long-term viability, market performance, and its role as a high-volatility sentiment amplifier linked to political developments.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

Viking Therapeutics is under intense pressure as investors express frustration over price stagnation and management's perceived lack of urgency regarding clinical trial timelines. The community remains deeply divided, with some betting on a transformative buyout or breakthrough trial data, while others are aggressively shorting the stock, citing dilution fears and strong competition from larger industry players.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is trending as investors react to strong growth metrics in its prediction platform, with community sentiment fueled by optimism surrounding the upcoming World Cup and potential market consolidation. While retail participants are actively discussing the stock's recovery potential and institutional interest, debates persist over its long-term performance compared to high-growth tech sectors.

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is facing significant selling pressure as investors react to concerns over massive AI-related capital expenditures and potential share dilution. The community remains deeply divided, with some users highlighting the stock's long-term growth potential and strong ad revenue while others express frustration over declining performance and the company's aggressive spending strategy.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

The SPY is experiencing significant intraday whipsaw volatility as traders react to persistent inflation concerns, geopolitical tensions, and ongoing discussions surrounding the upcoming SpaceX IPO. Market participants are actively debating whether the current price action is a sustainable bullish move or a tactical "bull trap" designed to lure in liquidity before a larger correction.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is rallying behind optimistic Phase 1 data for subcutaneous BRIUMVI in myasthenia gravis and a new Phase 2 trial, fueling strong community sentiment regarding the drug's expanding addressable market and potential for a significant buyout. Investors are closely monitoring management's commentary and upcoming clinical catalysts, as the stock pushes toward yearly highs amid mounting pressure on short sellers.

GE Vernova, Inc. engages in the electric power industry. It operates through the following segments: Power, Wind, and Electrification. The Power segment offers design, manufacture, and servicing gas, nuclear, hydro, and steam technologies, providing a critical foundation of dispatchable, flexible, stable, and reliable power. The Wind segment manages wind generation technologies, including onshore and offshore wind turbines and blades. The Electrification segment refers to the grid solutions, power conversion, electrification software, and solar and storage solutions technologies required for the transmission, distribution, conversion, storage, and orchestration of electricity from point of generation to point of consumption. The company was founded November 9, 2021 and is headquartered in Cambridge, MA.

GE Vernova Inc.

GE Vernova is experiencing significant volatility as investors weigh its robust backlog for grid infrastructure against broader market concerns regarding sector valuation. The community remains focused on the company's critical role in the data center power bottleneck, debating whether current price levels offer a buying opportunity or a signal of overextension.

United States Antimony Corp. engages in the extraction, processing and sale of antimony, zeolite, silver, and gold products. It operates through the following segments: United States Antimony Operations, Mexican Antimony Operations, Precious Metals Recovery, and United States Zeolite Operations. The company was founded by John C. Lawrence in June 1968 and is headquartered in Dallas, TX.

United States Antimony Corp.

United States Antimony Corp. is trending as investors closely monitor the commissioning of its new antimony smelter and potential government supply contracts while expressing frustration over stock price volatility and the lack of official corporate updates. Community discussion remains polarized, with many longs focused on the strategic importance of critical minerals and potential short squeezes, while others vent about institutional manipulation and persistent delays in execution.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$EME Insider Sale: $2.5M of stock sold by Frank Macinnis (Director) between December 7, 2011 - December 8, 2011 http://stks.co/1TcJ

NORWALK, CT - Frank Macinnis sold 99,482 shares of Emcor Group Inc stock, or $2,494,899 worth, as noted in an SEC Filing today. After the transaction, Frank Macinnis's stake was reported as 656,682 shares of Emcor Group Inc stock (a 13% decrease from before the transaction took place).

Marketbrief

Emcor Group Inc (EME): $2.5M of stock sold by Frank Macinnis; 4 Additional Transactions

Stocktwits

Emcor Group, Inc.

 Insider Sale: $2.5M of stock sold by Frank Macinnis (Director) between December 7, 2011 - December 8, 2011 